A number of genes have been proposed to be involved with drug resistance in ovarian cancer including the P-glycoprotein efflux transporter (PGP), anti-apoptotic proteins and other survival pathways (Richardson and Kaye, 2005). The gene discussed is PGP; the disease is ovarian carcinoma.